Top of the morning to you. Another cloudy day is unfolding here on the Pharmalot corporate campus, where we are, once again, hustling to deposit assorted short people at their school houses and preparing for a television taping this evening. To jumpstart our neurons, yes, we are quaffing a cup or two of stimulation and invite you to join us. After all, your own nerve endings might need a little help. In any event, here is the usual menu of tidbits. Have a successful day and keep in touch...
Innovative Drugs May Win FDA Approval After Early Trials (Bloomberg News)
Dr. Reddy's Makes An Unconditional Offer For Octopus (Hindu Business Line)
Eli Lilly Will Keep Its Animal Health Business (Reuters)
Amgen And UCB Halt Testing On Drug For Healing Fractures (Associated Press)
Glaxo Gets Speedy EU Review For Melanoma Drug (Pharma Times)
Europe Pushes To Keep Lethal Injection Drugs From US Prisons (Bloomberg News)
Drugmakers Eye Africa's Middle Class As Next Growth Market (Reuters)
EDITOR'S NOTE: Please check this post for additional items during the day
kettle pic thx to mirahartford on flickr
1 Comment